Metraipolis › archive › dc_d645e9794e91

Relationship of nutritional or systemic inflammatory markers with efficacy of gemcitabine and cisplatin with or without durvalumab therapy for patients with… — Europe PMC PMID:41699705

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41699705
DOI
10.1186/s40780-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-05T18:15:06.064Z
SHA-256 of the archived text
c7329fbf37b790eb68f5d9ea6cc018e9b2aa99effa062d337ace7807e97635b5
Stable URL of this page
https://metraipolis.com/documento/dc_d645e9794e91

How to cite

Relationship of nutritional or systemic inflammatory markers with efficacy of gemcitabine and cisplatin with or without durvalumab therapy for patients with… — Europe PMC PMID:41699705 — Europe PMC (en), https://europepmc.org/article/MED/41699705 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d645e9794e91 (Metraipolis archive dc_d645e9794e91, sha256 c7329fbf37b790eb68f5d9ea6cc018e9b2aa99effa062d337ace7807e97635b5)
BibTeX
@misc{dcd645e9794e91,
  title = {Relationship of nutritional or systemic inflammatory markers with efficacy of gemcitabine and cisplatin with or without durvalumab therapy for patients with… — Europe PMC PMID:41699705},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41699705},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d645e9794e91; sha256 c7329fbf37b790eb68f5d9ea6cc018e9b2aa99effa062d337ace7807e97635b5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41699705. Agents can read the archived copy with the MCP tool read_document.